Journal article icon

Journal article

Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion.

Abstract:

Interferon-alpha-2b (IFNalpha2b) is the only effective adjuvant therapy for melanoma patients at high risk of recurrence that has been approved by regulatory authorities worldwide. However, IFN toxicities increase the risk of poor treatment compliance and impair the potential for benefit from this agent. A review of the literature demonstrated little recent attention to supportive care in the management of IFN toxicities. An international group of experts with extensive personal experience in...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1002/cncr.23251

Authors


Expand authors...
Journal:
Cancer
Volume:
112
Issue:
5
Pages:
982-994
Publication date:
2008-03-05
DOI:
EISSN:
1097-0142
ISSN:
0008-543X
URN:
uuid:6193af00-34c2-4460-8a83-8140f20ba33b
Source identifiers:
120072
Local pid:
pubs:120072

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP